NEW YORK (Reuters Health) – Remdesivir reduces the presence of Ebola virus RNA in the semen of Ebola survivors, according to results of the PREVAIL IV study. “Ebola virus RNA persists in the semen of male Ebola survivors for months to years after the acute infection and male-to-female sexual transmission of the virus is well
FILE PHOTO: Children come forward to get their feet disinfected after a Red Cross worker explained that they are spraying bleach, and not spraying the village with the Ebola virus, in Forecariah January 30, 2015, REUTERS/Misha HussainGENEVA (Reuters) – Guinea’s current Ebola outbreak is likely to have been sparked by a latent infection in the
The Democratic Republic of Congo on Wednesday declared the end of the country’s latest Ebola epidemic, after the outbreak killed 55 people over the past five months. “I am happy to solemnly declare the end of the 11th epidemic of the Ebola virus in Equateur province” in the vast country’s northwest, Health Minister Eteni Longondo
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses. The world cannot afford to take our eye of other threats, says Flinders University Professor Nikolai Petrovsky, who warns the highly lethal and infectious Ebola virus could appear in a more virulent form.
The world health organization (WHO) considers that a new epidemic of Ebola for “inevitable”, but is better prepared than at the outbreak of the disease in West Africa by the end of 2013. Experts agree that the disease break out again and that there will be a new epidemic, said WHO Director Margaret Chan on
Scientists studying scarlet fever have identified a new strain of disease-causing bacteria, which may explain a rise in more serious Strep A infections in England and Wales, according to results from cases in London and across England and Wales from 2014-16 published in The Lancet Infectious Diseases journal. In 2014, England experienced the biggest surge
Scientists have discovered that 2 years after infection, West African Ebola survivors exhibit memory immune responses—including specific T cells against Ebola virus. They believe their discovery opens up the possibility of improving Ebola vaccines by boosting key immune cells needed for long-lasting protective immunity. The new research is being presented at this year’s European Congress
Ebola virus particles (red) on a larger cell. Credit: NIAID The number of cases in a nearly eight-month-old epidemic of Ebola in eastern DR Congo now exceeds 1,000, almost two-thirds of whom have died, the health ministry said late Sunday. “The accumulated number of cases is 1,009,” of which 629 cases were fatal, it said.
The organization Doctors without borders is sounding the Alarm: In the Democratic Republic of the Congo is the largest Ebola epidemic, which has existed in the country ever rages, and she is out of control. Seven months ago, the disease broke out in the Republic of the Congo. Until now, there were more than 900
Malaria, which claims hundreds of thousands of lives each year — mainly children and especially in Africa -, is one of the leading causes of death by an infectious agent, the Plasmodium falciparum parasite. In research on malaria, the genetic mutation that causes sickle cell anemia (also known as drepanocytosis), a chronic disease that is
Ebola death toll tops 500 in Democratic Republic of the Congo with nearly 100 CHILDREN killed by the devastating virus The second worst outbreak in history has ravaged the country since August Expected to continue into middle of the year at least, according to aid workers Thousands of vaccinations administered to neighbouring countries on high
Researchers have discovered a human protein that helps fight the Ebola virus and could one day lead to an effective therapy against the deadly disease, according to a new Northwestern Medicine study. The newly discovered ability of the human protein RBBP6 to interfere with Ebola virus replication suggests new ways to fight the infection. As
Researchers at Vanderbilt University Medical Center and colleagues have isolated a human monoclonal antibody that can “neutralize” the West Nile virus and potentially prevent a leading cause of viral encephalitis (brain inflammation) in the United States. Their findings, reported this week in the journal Nature Microbiology, could lead to the first effective treatment for this
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published online in Cell Reports, showed that DMAbs were expressed over a wide window of time and offered complete and long-term protection against lethal virus challenges. DMAbs may also
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published online in Cell Reports, showed that DMAbs were expressed over a wide window of time and offered complete and long-term protection against lethal virus challenges. DMAbs may also
In a new study researchers have developed a two-pronged approach for targeting Ebola virus infection using linked nucleic acid (LNA) antisense oligonucleotides (ASOs)designed to interfere both genes essential for translation of Ebola virus genes and to block production of an intracellular human protein needed for the virus to enter cells. The results of using LNA
The emergencies chief for the World Health Organization says insecurity, public defiance about vaccinations and political jockeying could create a “perfect storm” leading Congo’s latest Ebola outbreak to spread. Dr. Peter Salama says the response is at a “critical juncture” in eastern North Kivu province, where the outbreak was declared nearly two months ago. Health
When the Ebola virus struck West Africa in 2014, it resisted early attempts at control. It took more than two years to overcome, claiming more than 11,000 lives. Volunteers from the West who were infected were flown home and treated with experimental therapies, while those on the ground in Sierra Leone, Liberia and Guinea were
Ebola death toll climbs to 36 in the Democratic Republic of Congo as health officials begin a mass vaccination campaign Officials in the African nation have only confirmed 9 deaths so far through tests But they believe the lethal virus is responsible for scores more in the country A mass vaccination campaign will begin today
MONDAY, Aug. 6, 2018 — The number of confirmed cases in a new Ebola outbreak in Congo has reached 13, including three deaths, the country’s health ministry said late Saturday. It also said there were 30 probable cases and 33 suspected cases, the Associated Press reported. The new outbreak in North Kivu province was announced
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok